Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

被引：1
|
作者：
Ng, Chin-Hin [1 ]
Chen, Xiaojuan [1 ]
Lee, Foong-Gwan [1 ]
Choong, Shi Hui Clarice [1 ]
Saw, Xiao-Shi [2 ]
Sai, Lon-Wann [1 ]
Poon, Michelle [1 ]
Chan, Hian Li Esther Hian Li [1 ]
Ooi, Melissa [1 ]
Chee, Yen Lin [1 ]
Lee, Yee Mei [1 ]
机构：
[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Pharm, Singapore, Singapore
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID-LEUKEMIA
    MARCUS, RE
    CATOVSKY, D
    GOLDMAN, JM
    GALTON, DAG
    NEWLAND, AC
    SLOCOMBE, G
    HEGDE, U
    LANCET, 1985, 1 (8442): : 1384 - 1384
  • [22] Outpatient Administration of Liposomal Daunorubicin and Cytarabine (Vyxeos) in Patients With Secondary Acute Myeloid Leukemia
    Kasner, Margaret T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 604 - 606
  • [23] Antimicrobial prophylaxis during high dose cytarabine consolidation in acute myeloid leukemia
    Ingham, Randall
    Cardin, Michael
    Reagan, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
    Bashir, Yasir
    Geelani, Sajjad
    Bashir, Nusrat
    Mir, Shabeer A.
    Mushtaq, Mosin
    Jan, M. Aleem
    Rasool, Javid
    SOUTH ASIAN JOURNAL OF CANCER, 2015, 4 (01) : 4 - 6
  • [25] Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis
    Sljivic, Igor
    Fulford, Adrienne
    Ho, Jenny
    Lazo-Langner, Alejandro
    Xenocostas, Anargyros
    Deotare, Uday
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 888 - 894
  • [26] Prognostic significance of cytogenetic abnormalities in adult acute myeloid leukemia patients treated with high dose cytarabine
    Garson, OM
    Matthews, JP
    Bishop, JF
    BLOOD, 1995, 86 (10) : 2386 - 2386
  • [27] High Dose Cytarabine Is Superior to Intermediate Dose Cytarabine As Post-Remission Therapy for Younger Patients with Favorable Risk Acute Myeloid Leukemia
    Halim, Nurul Aidah Abdul
    Wong, Gee Chuan
    Aloysius, Ho Y. L.
    Hwang, William Y. K.
    Linn, Yeh Ching
    Lao, Zhentang
    BLOOD, 2016, 128 (22)
  • [28] INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Gil, Perez Angela
    Vazquez, Ramo Alejandro
    De Rojas, de Pablo Teresa
    Torralba, Gomez de Suso Miguel
    Nuevo, Lopez Irene
    Subira, Perez Dolores
    Merchan, Munoz Beatriz
    Perez, Ortega Alba
    De Miguel, Llorente Dunia
    HAEMATOLOGICA, 2020, 105 : 384 - 385
  • [29] High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21)
    Palmieri, S
    Sebastio, L
    Mele, G
    Annunziata, M
    Annunziata, S
    Copia, C
    Viola, A
    De Simone, M
    Pocali, B
    Schiavone, EM
    Ferrara, F
    LEUKEMIA RESEARCH, 2002, 26 (06) : 539 - 543
  • [30] Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older
    Vives, Susana
    Oriol, Albert
    Piernas, Sonia
    Brunet, Salut
    Clapes, Victoria
    Guardia, Ramon
    Subira, Maricel
    Sierra, Jordi
    Ribera, Josep-Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (06) : 576 - 582
12345